Skip to main content

MECANISMOS INMUNO-REGULADORES EN LA COMUNICACION CELULA-CELULA: CONTACTOS SINAPTICOS PROMOTORES DEL ESTADO DE ALERTA EN CELULAS INMUNES

SAF2017-82886-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO LA PRINCESA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Targeting the integrin interactome in human disease

  • Vicente-Manzanares, Miguel
  • Sánchez-Madrid, Francisco
Integrins comprise one of the most important families of cell–cell or cell–matrix adhesion receptors. Integrin interaction with their extracellular ligands is tunable by microenvironment signals, such as chemokines and growth factors, which modulate their interaction with other transmembrane proteins and cytoplasmic interactors. Integrins are important in different disease contexts, particularly inflammatory diseases and cancer. Clinical trials targeting integrins began in the early 2000s, leading to an increasingly clear picture: agents against integrins and their interactome control inflammatory diseases; whereas their efficacy as anti-cancer targets remains dubious. Here, we discuss the success of integrin targeting to treat autoimmunity and its failure in cancer, which is rooted in the plasticity and adaptability of the cancer cell., MV-M acknowledges funding from the Spanish Ministry of Economy and Innovation (MINECO), Grants SAF2014-54705-R and SAF2017-84708-R and from the Universidad de Salamanca (title XI). FS-M research is funded by grants from the Spanish Ministry of Economy and Competitiveness (Grants SAF2014-55579-R and SAF2017-82886-R), CIBER CARDIOVASCULAR from the Instituto de Salud Carlos III (Fondo de Investigación Sanitaria del Instituto de Salud Carlos III with co-funding from the Fondo Europeo de Desarrollo Regional; FEDER), Programa de Actividades en Biomedicina de la Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE and ERC-2011-AdG294340-GENTRIS.